UnitedHealth Group Incorporated $UNH Stock Holdings Increased by Penobscot Investment Management Company Inc.

Posted by Brian Himes on Oct 28th, 2026

Penobscot Investment Management Company Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,601 shares of the healthcare conglomerate’s stock after buying an additional 2,098 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in UnitedHealth Group were worth $8,663,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Corient Private Wealth LP bought a new stake in shares of UnitedHealth Group in the second quarter worth about $245,516,000. Legal & General Group Plc bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $2,019,844,000. BlackRock Inc. grew its position in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $971,757,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have commented on UNH. Bank of America restated a “buy” rating and set a $450.00 target price on shares of UnitedHealth Group in a report on Monday, July 20th. Argus upped their price target on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a report on Monday, July 20th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a research report on Friday, October 16th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $463.93.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 0.0%

NYSE:UNH opened at $410.72 on Wednesday. The stock has a 50-day simple moving average of $389.07 and a 200 day simple moving average of $361.44. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the firm posted $2.59 EPS. The company’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.